Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-transplant Lymphoproliferative Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01822509
What this trial is testing

Ipilimumab or Nivolumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell Transplant

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplant RecipientMyeloproliferative NeoplasmRecurrent Acute Lymphoblastic Leukemia+8 more
National Cancer Institute (NCI) 71
Large-scale testing (Phase 3)Active Not RecruitingNCT02659293
What this trial is testing

Trial of Carfilzomib, Lenalidomide, Dexamethasone Versus Lenalidomide Alone After Stem-cell Transplant for Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Chicago 180
Testing effectiveness (Phase 2)WithdrawnNCT00005998
What this trial is testing

Peripheral Stem Cell Transplantation With Specially Treated Stem Cells in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease

Who this might be right for
Lymphoma
Masonic Cancer Center, University of Minnesota
Testing effectiveness (Phase 2)Looking for participantsNCT05344833
What this trial is testing

Post-Autologous Transplant Maintenance With Isatuximab and Lenalidomide in Minimal Residual Disease Positive Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Illinois at Chicago 50
Testing effectiveness (Phase 2)UnknownNCT03091933
What this trial is testing

Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion)

Who this might be right for
Hematologic CancerRelapse LeukemiaRelapsed Adult ALL+6 more
Ciusss de L'Est de l'Île de Montréal 20
Testing effectiveness (Phase 2)Study completedNCT05991973
What this trial is testing

Low-dose Chidamide Maintenance Therapy After Allo-HSCT for T-cell Acute Lymphoblastic Leukemia or T-cell Lymphomas

Who this might be right for
T Lymphoblastic Leukemia/Lymphoma
Zhejiang University 44
Testing effectiveness (Phase 2)Study completedNCT01241734
What this trial is testing

Study of Lenalidomide in Combination With RICE With Lenalidomide Maintenance Post-Auto Transplant for DLBCL

Who this might be right for
Diffuse Large B Cell Lymphoma
Hackensack Meridian Health 18
Early research (Phase 1)Study completedNCT01362452
What this trial is testing

Infusion of Allogeneic Umbilical Cord Blood-Derived Cluster of Differentiation Antigen 19 (CD19)-Specific T Cells

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 5
Testing effectiveness (Phase 2)Study completedNCT00619684
What this trial is testing

Lenalidomide in Treating Patients With Progressive or Recurrent Multiple Myeloma After a Donor Stem Cell Transplant

Who this might be right for
Refractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more
Fred Hutchinson Cancer Center 18
Testing effectiveness (Phase 2)Study completedNCT00144703
What this trial is testing

Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation

Who this might be right for
Hematologic MalignanciesMyelogenous LeukemiaAcute Lymphoblastic Leukemia+3 more
Dana-Farber Cancer Institute 55
Testing effectiveness (Phase 2)Study completedNCT00003153
What this trial is testing

Biological Therapy in Treating Patients With Multiple Myeloma That Has Recurred Following Bone Marrow Transplantation

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Eastern Cooperative Oncology Group 22
Testing effectiveness (Phase 2)Study completedNCT00105001
What this trial is testing

Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

Who this might be right for
Myelodysplastic/Myeloproliferative Neoplasm, UnclassifiablePreviously Treated Myelodysplastic SyndromeRefractory Chronic Lymphocytic Leukemia+113 more
Fred Hutchinson Cancer Center 210
Testing effectiveness (Phase 2)Study completedNCT00031642
What this trial is testing

Monoclonal Antibody Therapy in Relapsed Non-Hodgkin's After Chemotherapy and Autologous Stem Cell Transplantation

Who this might be right for
Lymphoma
University of Nebraska 26
Large-scale testing (Phase 3)Active Not RecruitingNCT02390869
What this trial is testing

Rituximab and Lenalidomide vs Rituximab Alone as Maintenance After R-chemoterapy for Relapsed/Refractory FL Patients

Who this might be right for
Lymphoma, Follicular
Fondazione Italiana Linfomi - ETS 128
Testing effectiveness (Phase 2)Ended earlyNCT00632827
What this trial is testing

Treatment of PTCL With Aggressive Induction Therapy Followed by Autologous SCT Using Denileukin Diftitox (Ontak)

Who this might be right for
Peripheral T-Cell Lymphoma
University of California, San Francisco 21
Not applicableStudy completedNCT00956475
What this trial is testing

Quality of Life in Younger Leukemia and Lymphoma Survivors

Who this might be right for
Anxiety DisorderCancer SurvivorFatigue+7 more
Case Comprehensive Cancer Center 48
Testing effectiveness (Phase 2)UnknownNCT06427330
What this trial is testing

Phase II Study of Post-Transplant Low-Dose Inotuzumab Ozogamicin to Prevent Relapse of Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoid Leukemia
Institute of Hematology & Blood Diseases Hospital, China 21
Testing effectiveness (Phase 2)Ended earlyNCT02763254
What this trial is testing

Cellular Immunotherapy for Viral Induced Cancer - EBV Positive Lymphomas

Who this might be right for
Hodgkin LymphomaLymphoma, Large B-Cell, DiffusePost-transplant Lymphoproliferative Disorder
Cell Medica Ltd 1
Testing effectiveness (Phase 2)Ended earlyNCT01805037
What this trial is testing

Brentuximab Vedotin + Rituximab as Frontline Therapy for Pts w/ CD30+ and/or EBV+ Lymphomas

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+114 more
Northwestern University 20
Large-scale testing (Phase 3)Active Not RecruitingNCT04071457
What this trial is testing

S1803, Lenalidomide +/- Daratumumab/rHuPh20 as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration

Who this might be right for
Multiple Myeloma
SWOG Cancer Research Network 1,100
Next Page